|
GSPT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.202220E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.344600E-03 |
| Normal-vs-Stage2 |
1.082020E-01 |
| Normal-vs-Stage3 |
5.580600E-01 |
| Normal-vs-Stage4 |
5.902600E-01 |
| Stage1-vs-Stage2 |
9.171000E-01 |
| Stage1-vs-Stage3 |
2.108600E-01 |
| Stage1-vs-Stage4 |
5.375800E-01 |
| Stage2-vs-Stage3 |
4.136400E-01 |
| Stage2-vs-Stage4 |
6.405400E-01 |
| Stage3-vs-Stage4 |
8.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.388360E-02 |
| Normal-vs-AfricanAmerican |
2.164500E-02 |
| Normal-vs-Asian |
5.631800E-01 |
| Caucasian-vs-AfricanAmerican |
6.924000E-01 |
| Caucasian-vs-Asian |
9.545200E-01 |
| AfricanAmerican-vs-Asian |
8.440000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.260700E-03 |
| Normal-vs-Female |
6.144200E-01 |
| Male-vs-Female |
3.864400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.388400E-02 |
| Normal-vs-Extreme_Weight |
4.230600E-04 |
| Normal-vs-Obese |
3.537400E-01 |
| Normal-vs-Extreme_Obese |
7.904200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.670600E-01 |
| Normal_Weight-vs-Obese |
2.079000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.231200E-01 |
| Extreme_Weight-vs-Obese |
2.298300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.880200E-01 |
| Obese-vs-Extreme_Obese |
1.977040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.153600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.491600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.400400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.982800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.108000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.001900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.909700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.656200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.624580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.863200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.743100E-03 |
| Normal-VS-Type2 PRCC |
5.450300E-02 |
| Normal-VS-KIRP CIMP |
2.739600E-01 |
| Normal-VS-Unclassified PRCC |
7.897000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.093000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.355500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.534000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.220000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.492200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.276400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.403100E-03 |
| Normal-vs-N1 |
9.862200E-01 |
| Normal-vs-N2 |
9.460800E-01 |
| N0-vs-N1 |
1.930320E-02 |
| N0-vs-N2 |
3.279800E-01 |
| N1-vs-N2 |
9.170200E-01 |
|
|
